Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...

Spero will now have funding to start a new phase 3 trial of the drug – tebipenem pivoxil hydrobromide, to give it its full name – and according to GSK this will be designed based on feedback ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

For new and old investors, taking full advantage of the stock market and ... with a #1 or #2 Rank and Scores of A or B, the better. GSK has three segments: Specialty Medicines (HIV, Oncology ...